Seeking Alpha·Oct 29, 2026
Proto Labs, Inc. (PRLB) Q3 2026 Earnings Call TranscriptProto Labs, Inc. (PRLB) Q3 2026 Earnings Call Transcript
Proto Labs' revenue grew 14.0% year over year to $154.3M in 2026Q3, reversing negative growth seen in early 2025, which suggests demand momentum may be recovering.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Oct 29, 2026 | $0.63+5.7% vs $0.60 | $154M+3.4% vs $149M |
Q3 2026 Jul 31, 2026 | $0.60+13.2% vs $0.53 | $149M+3.3% vs $145M |
Q2 2026 May 1, 2026 | $0.54+35.0% vs $0.40 | $139M+3.0% vs $135M |
Q1 2026 Feb 6, 2026 | $0.44+25.7% vs $0.35 | $136M+5.8% vs $129M |
Proto Labs, Inc. (PRLB) Q3 2026 Earnings Call Transcript
Proto Labs (PRLB) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.6 per share. This compares to earnings of $0.47 per share a year ago.
MINNEAPOLIS--(BUSINESS WIRE)--Proto Labs, Inc. ("Protolabs" or the "Company") (NYSE: PRLB), the world's leading provider of digital manufacturing services, today announced financial results for the third quarter ended September 30, 2026. Third Quarter 2026 Financial Highlights: Revenue was a record $154.3 million, a 14.0% increase over the third quarter of 2025. Total revenue per customer contact increased 16.6% year-over-year. CNC machining revenue grew 16.4% year-over-year. Injection molding.
Proto Labs, an entity that offers automated digital manufacturing services, has outperformed other small-cap industrials stocks by 10x on a YTD basis. PRLB is due to report Q3 results on the 29th of October and is set to deliver a 4th successive quarter of top line growth, although sturdy gross margins could abate. Stabilization on customer counts as well as double-digit growth on the revenue per customer front could be taken well.
Benchmark PRLB against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Proto Labs, Inc. (PRLB)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $65.69 | $1.56B | 45.84 | 6.44% | 6.04% | 5.09% | — | |
| $6.42 | $557.35M | -4.85 | -3.73% | -21.05% | -13.8% | — | |
| $114.95 | $6.18B | -402.06 | 25.87% | -1.97% | -3.9% | — | |
| $6.75 | $395.25M | 27.51 | -3.63% | 4.65% | 4.98% | — | |
| $1.32 | $277.87M | -1.85 | 77.3% | -118.38% | -30.55% | — | |
| $195.07 | $22.53B | 20.65 | -0.21% | 37.8% | 28.34% | — |
Proto Labs, Inc. (PRLB) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Proto Labs, Inc. (PRLB) SEC filings — annual & quarterly reports (10-K, 10-Q)
Oct 29, 2026·SEC
Jul 31, 2026·SEC
May 20, 2026·SEC
Get notified when PRLB posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Proto Labs, Inc. (PRLB) stock FAQ — growth, dividends, profitability & financials explained
Proto Labs, Inc. (PRLB) reported $579.5M in revenue over the trailing twelve months. Revenue was $533.1M in fiscal year 2025. That is 1116% more than the $43.8M of fiscal year 2009.
Proto Labs, Inc. (PRLB) grew revenue by 11.8% over the trailing twelve months, compared with the twelve months before.
Yes. Proto Labs, Inc. (PRLB) earned $35.0M in net income over the trailing twelve months (a 6.0% net margin).
Proto Labs, Inc. (PRLB) had a return on equity (ROE) of 5.1% over the trailing twelve months. That is below the market's typical 10-15%.
Proto Labs, Inc. (PRLB) generated $48.6M in free cash flow over the trailing twelve months.
